DNA methylation of microRNA-375 in impaired glucose tolerance

Area of Science:

• Molecular Biology
• Endocrinology
• Epigenetics

Background:

• MicroRNAs (miRNAs) play crucial roles in regulating gene expression.
• Aberrant miRNA expression and epigenetic modifications are implicated in metabolic disorders like type 2 diabetes mellitus (T2DM).
• The specific role of miRNA-375 (miR-375) in glucose tolerance and T2DM pathogenesis requires further investigation.

Purpose of the Study:

• To analyze the expression levels and DNA methylation status of miR-375 in patients with normal glucose tolerance (NGT), impaired glucose tolerance (IGT), and T2DM.
• To investigate the potential role of miR-375 DNA methylation in the pathogenesis of T2DM.

Main Methods:

• Plasma samples were collected from patients diagnosed with NGT, IGT, and T2DM.
• Expression levels of miR-375 were quantified using appropriate molecular assays.
• DNA methylation status of the miR-375 promoter region, including specific CpG units, was analyzed.

Main Results:

• Plasma miR-375 levels were downregulated in IGT patients and upregulated in T2DM patients compared to NGT controls.
• Significant hypermethylation of the miR-375 promoter was observed in IGT patients compared to both NGT and T2DM patients.
• Specific CpG units within the miR-375 promoter showed increased methylation in IGT patients, correlating with downregulated miR-375 expression.

Conclusions:

• The study demonstrates that miR-375 promoter hypermethylation is associated with downregulated plasma miR-375 levels in patients with IGT.
• DNA hypomethylation of miR-375 may play a role in regulating its expression and potentially contribute to the pathogenesis of T2DM.
• These findings highlight the epigenetic regulation of miR-375 as a potential factor in glucose metabolism disturbances.